Search clinical trials for: MBG453
Total 17 results
-
Massachusetts General HospitalNovartisRecruiting
-
Novartis PharmaceuticalsActive, not recruitingMyelodysplastic SyndromesUnited States, Spain, Italy, Singapore, Korea, Republic of, Israel, Australia
-
Novartis PharmaceuticalsActive, not recruitingMyelofibrosisUnited Kingdom, Australia, Canada, Switzerland, Netherlands, Spain, Germany, Italy, Turkey, Russian Federation, Sweden, Denmark, Hungary
-
Fundación de investigación HMMichael J. Fox Foundation for Parkinson's Research; Hospital San Carlos, Madrid and other collaboratorsCompletedParkinson's Disease | Dyskinesia, Medication-InducedSpain
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Spain, Singapore, Australia, Germany, Italy, Finland, United States
-
Novartis PharmaceuticalsActive, not recruitingMyelodysplastic SyndromesCzechia, Hungary, Japan, Taiwan, United States, Belgium, Italy, United Kingdom, Korea, Republic of, Hong Kong, Austria, Germany, Turkey, Spain, Greece, France, Canada
-
Novartis PharmaceuticalsActive, not recruitingMyelodysplastic Syndromes | Leukemia, Myelomonocytic, ChronicChina, Czechia, Japan, Saudi Arabia, Taiwan, Turkey, Germany, Spain, Netherlands, Italy, Singapore, Australia, Austria, France, United Kingdom, Korea, Republic of, Thailand, Israel, Belgium, Canada, Switzerland, Lithuania, Russian Federation and more
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid LeukemiaSpain, Germany, France, Italy
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Novartis PharmaceuticalsActive, not recruitingGlioblastoma MultiformeUnited States
-
Novartis PharmaceuticalsRecruitingMyelodysplastic Syndrome (MDS)United States
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid LeukemiaItaly, Spain, Canada, Germany, Korea, Republic of, Japan, Australia, France, United States, Taiwan
-
Novartis PharmaceuticalsWithdrawnPrimary Myelofibrosis | Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | PMF | Post-Essential Thrombocythemia Myelofibrosis
-
Novartis PharmaceuticalsWithdrawnAcute Myeloid Leukemia | Myelodysplastic Syndromes
-
Novartis PharmaceuticalsTerminatedAdvanced MalignanciesTaiwan, Netherlands, Italy, Korea, Republic of, Japan, United States, Switzerland, Canada, Singapore
-
Novartis PharmaceuticalsCompletedMyelodysplastic Syndromes | Bone Marrow Diseases | Hematologic Diseases | Leukemia | Leukemia, Myeloid | Leukemia, Myeloid, Acute | Preleukemia | Chronic Myelomonocytic LeukemiaUnited States, France, Australia, Netherlands, Spain, Germany, United Kingdom, Finland
-
Novartis PharmaceuticalsRecruitingMyelodysplastic Syndromes | Leukemia, Myelomonocytic, ChronicSpain, Italy, United States, Greece